LEADER 04263nam 22005895 450 001 9910734874303321 005 20200703011354.0 010 $a3-030-15398-3 024 7 $a10.1007/978-3-030-15398-4 035 $a(CKB)4100000008340761 035 $a(MiAaPQ)EBC5783565 035 $a(DE-He213)978-3-030-15398-4 035 $a(PPN)242824544 035 $a(EXLCZ)994100000008340761 100 $a20190601d2019 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPharmaceutical Supply Chains - Medicines Shortages /$fedited by Ana Paula Barbosa-Povoa, Helena Jenzer, João Luís de Miranda 205 $a1st ed. 2019. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2019. 215 $a1 online resource (268 pages) 225 1 $aLecture Notes in Logistics,$x2194-8917 311 $a3-030-15397-5 327 $aFrom the contents: The European Medicines Shortages Research Network and its mission to strategically debug disrupted pharmaceutical supply chains -- Design and Planning of Sustainable Vaccine Supply Chains -- Drug shortages and their impact on patients and health care system ? how can systemic and organizational frameworks help to prevent or mitigate them? -- Patient perspective: reporting on medicines shortages ? hemophilia A case in Latvia -- Shortages of Medicines originating from manufacturing -- Risk Mitigation and Preventing Medicines Shortages -- An Exploratory Assessment of Risk and Resilience in Pharmaceutical Supply Chains -- Review of Pharmaceutical Sea Freight and Malaysian Third-Party Logistics Service Providers ? a Supply Chain Perspective -- The needs and barriers within the Supply Chain actors - Hospital Pharmacy needs -- Patients Perspectives on Medicines Shortages in Hospital Setting. 330 $aThis book provides an insight of relevant case studies and updated practices in ?Pharmaceutical Supply Chains? (PharmSC) while addressing the most relevant topics within the COST Action ?Medicines Shortages? (CA15105). The volume focuses on the most recent developments in the design, planning and scheduling of PharmSC, broadening from the suppliers? selection to the impact on patients and healthcare systems, addressing uncertainty and risk mitigation, and computational issues. It is directed at MSc/PhD students and young researchers (Post-Docs) in Pharmaceutics/Pharmaceutical sciences, Engineering fields, Economics/Management, as well as pharmaceutical decision makers, managers, and practitioners, and advanced readers demanding a fresh approach to decision making for PharmSC. The contributed chapters are associated with the homonymous COST Training Schools (TS), and the book creates a better understanding of the Action ?Medicines Shortages? challenges and opportunities. 410 0$aLecture Notes in Logistics,$x2194-8917 606 $aPharmaceutical technology 606 $aEngineering economy 606 $aEngineering economy 606 $aBusiness logistics 606 $aPharmaceutical Sciences/Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21010 606 $aEngineering Economics, Organization, Logistics, Marketing$3https://scigraph.springernature.com/ontologies/product-market-codes/T22016 606 $aSupply Chain Management$3https://scigraph.springernature.com/ontologies/product-market-codes/519030 615 0$aPharmaceutical technology. 615 0$aEngineering economy. 615 0$aEngineering economy. 615 0$aBusiness logistics. 615 14$aPharmaceutical Sciences/Technology. 615 24$aEngineering Economics, Organization, Logistics, Marketing. 615 24$aSupply Chain Management. 676 $a338.479151 676 $a615.10687 702 $aBarbosa-Povoa$b Ana Paula$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aJenzer$b Helena$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $ade Miranda$b João Luís$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910734874303321 996 $aPharmaceutical Supply Chains - Medicines Shortages$93404741 997 $aUNINA